The transaction started out as a hostile takeover bid, with Aurora entering into a lock - up agreement with four
major CanniMed shareholders.CanniMed's management retaliated by adopting a
tactical shareholder rights plan, which was in turn
challenged in court (and ultimately stuck down as an improper defensive tactic).